No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. - Wikidata - wikimedia - TriplyDB

No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes.

No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes.

http://www.wikidata.org/entity/Q33932615

about

Role of vitamin D in diabetes mellitus and chronic kidney disease Vitamin D and diabetes mellitus: an update 2013 Risk factors and primary prevention trials for type 1 diabetes Environmental risk factors for type 1 diabetes No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial.Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.Efficacy of supplementary vitamin D on improvement of glycemic parameters in patients with type 2 diabetes mellitus; a randomized double blind clinical trial Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential.Calcitriol plays a protective role in diabetic nephropathy through anti-inflammatory effects.Current concepts on the pathogenesis of type 1 diabetes--considerations for attempts to prevent and reverse the disease.Vitamin D deficiency in children and adolescents with type 1 diabetes Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY).Effect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetes.Primary and secondary prevention of Type 1 diabetes The role of vitamin D in the metabolic homeostasis of diabetic bone Nutritional factors and preservation of C-peptide in youth with recently diagnosed type 1 diabetes: SEARCH Nutrition Ancillary Study Vitamin D and immune function.Altered immune regulation in type 1 diabetes.Vitamin D intake and risk of type 1 diabetes: a meta-analysis of observational studies Association of serum 25-hydroxyvitamin D with insulin resistance and β-cell function in a healthy Chinese female population.Vitamin D and cardiovascular risk.Clinical immunologic interventions for the treatment of type 1 diabetes.Effects of vitamin D on antigen-specific and non-antigen-specific immune modulation: relevance for type 1 diabetes.Progress in immune-based therapies for type 1 diabetes.Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse.The latest pharmacotherapy options for type 1 diabetes.Role of vitamin D in acquired immune and autoimmune diseases.Therapies to Preserve β-Cell Function in Type 1 Diabetes.Combination Immunotherapy for Type 1 Diabetes.Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept.Treating vitamin D deficiency in children with type I diabetes could improve their glycaemic control.It's time to consider changing the rules: the rationale for rethinking control groups in clinical trials aimed at reversing type 1 diabetes.Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity.The Effects of Vitamin D Supplementation in Newly Diagnosed Type 1 Diabetes Patients: Systematic Review of Randomized Controlled Trials.T-lymphocyte and glycemic status after vitamin D treatment in type 1 diabetes: A randomized controlled trial with sequential crossover.Author's Reply to Dayal: "Therapies to Preserve β-Cell Function in Type 1 Diabetes".[Vitamin D : More than just a bone hormone].Comment on: “Therapies to Preserve β-Cell Function in Type 1 Diabetes”

P2860

Q26765231-F3554654-5774-4E48-92DB-E89BE6F1E6A4 Q26866542-B3AF22E5-C110-4E1C-ABDA-6164CDDB182B Q27005625-7C1AE567-E0AF-463E-A0E0-588B1531B85F Q28276366-4CAB7561-6C08-426A-A295-1EAD18F82B6B Q34084512-A98CE380-2B84-4E6C-A8F1-E16587D8EE56 Q34375578-A9B919B0-517F-4CBC-BD67-0CFCF45881C9 Q34385921-590E2A70-A7A3-4A81-9DC3-1BA217629E1D Q34550631-204091B5-36C7-4484-86C5-D7843D08304E Q35017214-18586BA2-1414-44A3-872F-8104956BACB3 Q35630698-FB4BBE36-A27B-4964-9D10-56582113071E Q35632286-FC12449B-24C7-4BE6-A274-7F11438870A0 Q36216535-B6D6ED4B-A4B5-49FD-9035-A66AFBFDC8F6 Q36340707-89446603-8A8A-4338-A314-DEF27DAE672D Q36625037-F1C94958-8A78-4544-9A8D-0718801CC676 Q36631971-821335AA-879A-4E8B-8341-CFDF18ABEF38 Q36783562-2D874483-5709-47BB-88AB-16DEC08E698E Q36942134-AC35AF1A-7FBA-4901-8F16-AAD65E34A99A Q37083785-F5BE1ECA-FB1E-40A0-A51A-D84524E5CCFF Q37148578-B53D2941-74F3-412D-96AC-F4D8215053E8 Q37235384-1F179283-C460-4C4B-904B-0CBD16F6C9A9 Q37729303-4B771384-17C6-4CD0-AC3E-DB990624A328 Q37997996-41283B82-D60D-46F4-A0B8-65CD38737395 Q38036230-2346CD24-B757-40F0-8D42-480683360B8D Q38047405-BB3F7583-1C7D-41CE-AD57-545BF6016D15 Q38097920-5742F2B8-76D9-4B86-B7B1-0C8A9009EB1E Q38135862-EAC17982-8526-42AD-BED5-9DE85C321FAE Q38167387-B51BCFDC-5980-49DF-AB05-3D64955CA091 Q38210581-D4BBCCB0-2E66-4AFB-B05E-08433490A398 Q38662048-52CE4339-002F-4A27-96AE-A3DBAEB7D1E6 Q38680333-5C1FE174-E8F9-4578-9564-94DFC5EBE759 Q39077798-9B510C77-DCD7-42E7-B092-07CE3FA00ABA Q41521356-B2BA77F8-364B-4146-9BC6-4738F4350868 Q42582344-63FCFD33-13B5-4CD8-B287-0E0C3354D0E7 Q45070802-95C8B37A-3006-42C5-909A-ED358306CA69 Q49960554-7B1E77A8-CF68-4104-AB97-A50893ECE47D Q50567211-2D6E3622-3C4D-4A4A-A698-B2E5894F84A0 Q52880569-4F4F088A-BF4D-487A-9007-5DB93DE44644 Q54574587-C9955E05-283E-41BD-B35C-1A5F2BAE0164 Q57704496-EFE87A65-BED1-4A15-9A31-D95616F5E8BF

P2860

No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes.

http://www.wikidata.org/entity/Q33932615

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

No effect of the 1alpha,25-dih ...... ith new-onset type 1 diabetes.

@ast

No effect of the 1alpha,25-dih ...... ith new-onset type 1 diabetes.

@en

type

label

No effect of the 1alpha,25-dih ...... ith new-onset type 1 diabetes.

@ast

No effect of the 1alpha,25-dih ...... ith new-onset type 1 diabetes.

@en

prefLabel

No effect of the 1alpha,25-dih ...... ith new-onset type 1 diabetes.

@ast

No effect of the 1alpha,25-dih ...... ith new-onset type 1 diabetes.

@en

P1433

Q33932615-07BDDD5A-B283-4F80-93CF-284E1243BBA5

P1476

Q33932615-381C1FA0-CF2A-45D1-99FC-152424A01BCB

P2093

Q33932615-31066227-E20A-4783-A94D-BB1142625E08

Q33932615-78E1AC21-D1D5-4307-A417-3B30B6A536A4

Q33932615-B13B6585-98F9-4628-A7DF-6AC0A83C17CE

Q33932615-B98B61F6-0C38-4E32-A815-1B555B859E21

Q33932615-F5E95DC9-165D-470A-8294-C8998F3C2873

P2860

Q33932615-083D132C-4897-41A6-B030-CE6060E385AF

Q33932615-11ED3053-8CAC-4993-8857-3C16CED9D537

Q33932615-121AF777-6CEC-4B1F-8A6D-8570DEAED313

Q33932615-138305A0-416D-40EE-B040-8669CD01A6A6

Q33932615-191953D8-CF60-4CC3-91BD-9233FDAC8959

Q33932615-43FE8301-FDBA-43BD-ADA4-9645153E11BF

Q33932615-4EBA6C8C-9B36-4E3B-B3B5-7E7F7714AA6B

Q33932615-5D36A024-062B-49EB-9019-AA05EFB6A255

Q33932615-69C28611-8C76-4D21-BBFC-EB48E08FE8E4

Q33932615-707CA34F-1C23-4C4D-926B-F95293FC9EC5

P304

Q33932615-A1770EC3-C69A-45B4-AF52-52F96FB87B69

P31

Q33932615-255C0098-1D2F-4041-83EF-D0BD761A3D65

P356

Q33932615-94823880-40AB-4B88-A37F-BA6CCEB30550

P407

Q33932615-3DC10534-40C5-4A10-99EA-CD1347EDA1DB

P433

Q33932615-CB1D0247-BB99-4C85-93AF-8500518AC734

P478

Q33932615-21666DF1-F10C-4B7F-937F-D63018686954

P50

Q33932615-919BA2E4-FBB4-4619-BA06-FAB6A5F5BBF5

P577

Q33932615-ACD8743D-6851-4838-B2BD-60C6C87F1419

P5875

Q33932615-BD3ACD3C-0952-4B62-B41C-2D43D2BC9968

P698

Q33932615-7F1A6612-A069-4B09-86C4-7B337F350A2D

P921

Q33932615-70EE2266-C93A-4E53-84C9-00AEB6E2D4F1

P932

Q33932615-4963809D-D931-4C18-8424-8B0249063147

P356

P1433

P1476

No effect of the 1alpha,25-dih ...... ith new-onset type 1 diabetes.

@en

P2093

Anette-G Ziegler

http://www.w3.org/2001/XMLSchema#string

Johannes Foersch

http://www.w3.org/2001/XMLSchema#string

Kerstin Adler

http://www.w3.org/2001/XMLSchema#string

Markus Walter

http://www.w3.org/2001/XMLSchema#string

Thomas Kaupper

http://www.w3.org/2001/XMLSchema#string

P2860

Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice

1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells.

Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome

Type 1 diabetes: new perspectives on disease pathogenesis and treatment.

Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo.

Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes.

Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis.

Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment.

P304

1443-1448

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC09-2297

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42806844

http://www.w3.org/2001/XMLSchema#string

P698

20357369

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

2890336

http://www.w3.org/2001/XMLSchema#string